Bioclub announced that it has received investment in a round of funding from new investor Hangzhou Tigermed Consulting Co., Ltd on August 7, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.75 CNY | -0.18% | +1.08% | +8.70% |
Apr. 25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
Apr. 25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.70% | 6.69B | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- Bioclub announced that it has received funding from Hangzhou Tigermed Consulting Co., Ltd